Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs.

PubWeight™: 1.66‹?› | Rank: Top 3%

🔗 View Article (PMID 15845451)

Published in Immunity on April 01, 2005

Authors

Cheng-Ming Sun1, Edith Deriaud, Claude Leclerc, Richard Lo-Man

Author Affiliations

1: Unité de Biologie des Régulations Immunitaires, INSERM E352, Institut Pasteur, 25 rue du Docteur Roux, 75724 Paris, Cedex 15, France.

Articles citing this

The regulation of IL-10 production by immune cells. Nat Rev Immunol (2010) 9.18

The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol (2010) 4.26

Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev (2010) 3.31

Cytokine-producing B lymphocytes-key regulators of immunity. Curr Opin Immunol (2008) 2.84

Development of TLR9 agonists for cancer therapy. J Clin Invest (2007) 2.64

Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus. Immunity (2009) 2.45

CpG DNA as a vaccine adjuvant. Expert Rev Vaccines (2011) 2.17

TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells. Eur J Immunol (2007) 2.15

B cells enhance early innate immune responses during bacterial sepsis. J Exp Med (2011) 1.99

Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol (2009) 1.88

Toll-like receptors--sentries in the B-cell response. Immunology (2009) 1.52

Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol (2012) 1.49

Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity. J Exp Med (2008) 1.46

Murine neonatal CD4+ cells are poised for rapid Th2 effector-like function. J Immunol (2007) 1.41

Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells. J Exp Med (2007) 1.39

TLR and B cell receptor signals to B cells differentially program primary and memory Th1 responses to Salmonella enterica. J Immunol (2010) 1.30

Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells. Immunology (2007) 1.16

Regulatory functions of innate-like B cells. Cell Mol Immunol (2013) 1.10

Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis. Autoimmunity (2012) 1.02

Interaction of neonatal phagocytes with group B streptococcus: recognition and response. Infect Immun (2006) 0.99

Human B cells induce dendritic cell maturation and favour Th2 polarization by inducing OX-40 ligand. Nat Commun (2014) 0.97

Interaction of Streptococcus agalactiae and Cellular Innate Immunity in Colonization and Disease. Front Immunol (2014) 0.95

Probiotics stimulate production of natural antibodies in chickens. Clin Vaccine Immunol (2006) 0.94

Differential pathological and immune responses in newly weaned ferrets are associated with a mild clinical outcome of pandemic 2009 H1N1 infection. J Virol (2012) 0.91

A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production. J Immunol (2014) 0.90

Purified neonatal plasmacytoid dendritic cells overcome intrinsic maturation defect with TLR agonist stimulation. Pediatr Res (2006) 0.90

Inhibition of IL-10 production by maternal antibodies against Group B Streptococcus GAPDH confers immunity to offspring by favoring neutrophil recruitment. PLoS Pathog (2011) 0.89

The modulatory effects of lipopolysaccharide-stimulated B cells on differential T-cell polarization. Immunology (2008) 0.89

Preexposure to CpG protects against the delayed effects of neonatal respiratory syncytial virus infection. J Virol (2012) 0.88

Infection of mice with respiratory syncytial virus during neonatal life primes for enhanced antibody and T cell responses on secondary challenge. Clin Exp Immunol (2008) 0.87

The interferon-alpha and interleukin-10 responses in neonates differ from adults, and their production remains partial throughout the first 18 months of life. Clin Exp Immunol (2010) 0.87

Ontogeny of myeloid cells. Front Immunol (2014) 0.87

Toll-like receptor signaling in transplantation. Curr Opin Organ Transplant (2008) 0.86

99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: neonatal immune function and vaccine responses in children born in low-income versus high-income countries. Clin Exp Immunol (2010) 0.85

Neonatal plasmacytoid dendritic cells (pDCs) display subset variation but can elicit potent anti-viral innate responses. PLoS One (2013) 0.85

The adjuvant LT-K63 can restore delayed maturation of follicular dendritic cells and poor persistence of both protein- and polysaccharide-specific antibody-secreting cells in neonatal mice. J Immunol (2012) 0.85

Cellular and molecular mechanisms underlying the strong neonatal IL-12 response of lamb mesenteric lymph node cells to R-848. PLoS One (2010) 0.83

Pulsed high-dose dexamethasone improves interleukin 10 secretion by CD5+ B cells in patients with primary immune thrombocytopenia. J Clin Immunol (2012) 0.83

Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells. F1000Res (2015) 0.83

Distinct TLR-mediated cytokine production and immunoglobulin secretion in human newborn naïve B cells. Innate Immun (2016) 0.82

Reprogramming of B cells into regulatory cells with engineered fusokines. Infect Disord Drug Targets (2012) 0.81

CpG-induced Th1-type response in the downmodulation of early development of allergy and inhibition of B7 expression on T cells of newborn mice. J Clin Immunol (2010) 0.81

Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases. Adv Pharm Bull (2015) 0.81

Porcine neonatal blood dendritic cells, but not monocytes, are more responsive to TLRs stimulation than their adult counterparts. PLoS One (2013) 0.80

Thymic and extrathymic contributions to T helper cell function in murine neonates. Haematol Rep (2006) 0.80

Dendritic cells and B cells: unexpected partners in Th2 development. J Immunol (2014) 0.80

L2pB1: a new player in autoimmunity. Mol Immunol (2010) 0.79

Increased activation and cytokine secretion in B cells stimulated with leptin in aged humans. Immun Ageing (2013) 0.79

Human neonatal dendritic cells are competent in MHC class I antigen processing and presentation. PLoS One (2007) 0.79

Inclusion of Flagellin during Vaccination against Influenza Enhances Recall Responses in Nonhuman Primate Neonates. J Virol (2015) 0.78

To B or not to B cells-mediate a healthy start to life. Clin Exp Immunol (2013) 0.77

Computer-aided designing of immunosuppressive peptides based on IL-10 inducing potential. Sci Rep (2017) 0.75

Regulatory T and B lymphocytes in a spontaneous autoimmune polyneuropathy. Clin Exp Immunol (2016) 0.75

B cells are dispensable for neonatal transplant tolerance induction. Transplantation (2009) 0.75

Characterization of the Highly Prevalent Regulatory CD24(hi)CD38(hi) B-Cell Population in Human Cord Blood. Front Immunol (2017) 0.75

The immune system as a self-centered network of lymphocytes. Immunol Lett (2015) 0.75

IL-12p40/IL-10 Producing preCD8α/Clec9A+ Dendritic Cells Are Induced in Neonates upon Listeria monocytogenes Infection. PLoS Pathog (2016) 0.75

Unique aspects of the perinatal immune system. Nat Rev Immunol (2017) 0.75

Articles by these authors

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med (2003) 5.97

Neonatal adaptive immunity comes of age. Nat Rev Immunol (2004) 5.31

Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. Immunity (2009) 3.52

Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. Infect Immun (2006) 2.56

Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP. PLoS Pathog (2008) 1.94

Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity. J Immunol (2002) 1.88

Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis. Nat Genet (2013) 1.67

Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity. J Biol Chem (2005) 1.64

Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. J Immunol (2005) 1.61

An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis. Infect Immun (2006) 1.51

CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules. J Exp Med (2002) 1.49

Developing a model of recovery in mental health. BMC Health Serv Res (2009) 1.40

Disruption of the ESX-5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation. Mol Microbiol (2012) 1.39

Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells. J Exp Med (2007) 1.39

Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines. Bioconjug Chem (2005) 1.36

Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation. Blood (2008) 1.32

Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6. Infect Immun (2004) 1.31

Ontogeny and innate properties of neonatal dendritic cells. Blood (2003) 1.30

High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection. Infect Immun (2006) 1.26

A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates. Cancer Res (2004) 1.26

Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J Immunol (2007) 1.25

Predictors and profiles of treatment non-adherence and engagement in services problems in early psychosis. Schizophr Res (2008) 1.20

CD8+-T-cell responses of Mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family. Infect Immun (2003) 1.18

The T-cell receptor repertoire of tumor-infiltrating regulatory T lymphocytes is skewed toward public sequences. Cancer Res (2012) 1.17

Murine plasmacytoid dendritic cells induce effector/memory CD8+ T-cell responses in vivo after viral stimulation. Blood (2004) 1.17

In vivo, dendritic cells can cross-present virus-like particles using an endosome-to-cytosol pathway. J Immunol (2003) 1.16

Interaction of Bordetella pertussis adenylate cyclase with CD11b/CD18: Role of toxin acylation and identification of the main integrin interaction domain. J Biol Chem (2003) 1.15

Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens. J Infect Dis (2004) 1.13

Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system. Cancer Res (2007) 1.11

ESAT-6 secretion-independent impact of ESX-1 genes espF and espG1 on virulence of Mycobacterium tuberculosis. J Infect Dis (2010) 1.09

The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo. J Immunol (2007) 1.08

Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming. J Immunol (2004) 1.06

Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells. Vaccine (2008) 1.05

TLR3 ligand stimulates fully functional memory CD8+ T cells in the absence of CD4+ T-cell help. Blood (2007) 1.04

Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein. Cancer Res (2005) 1.03

Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. J Nerv Ment Dis (2008) 1.01

Efficient in vivo priming of specific cytotoxic T cell responses by neonatal dendritic cells. J Immunol (2002) 1.01

Strong immunogenicity and cross-reactivity of Mycobacterium tuberculosis ESX-5 type VII secretion: encoded PE-PPE proteins predicts vaccine potential. Cell Host Microbe (2012) 1.01

Regulatory B and T cells in infections. Microbes Infect (2008) 1.01

Effect of attenuation of Treg during BCG immunization on anti-mycobacterial Th1 responses and protection against Mycobacterium tuberculosis. PLoS One (2008) 1.00

Enhanced ex vivo stimulation of Mycobacterium tuberculosis-specific T cells in human immunodeficiency virus-infected persons via antigen delivery by the Bordetella pertussis adenylate cyclase vector. Clin Vaccine Immunol (2007) 0.98

Acylation of lysine 860 allows tight binding and cytotoxicity of Bordetella adenylate cyclase on CD11b-expressing cells. Biochemistry (2005) 0.98

Virus-like particles: a new family of delivery systems. Expert Rev Vaccines (2002) 0.96

New tools for antigen delivery to the MHC class I pathway. Trends Immunol (2004) 0.96

Efficient Ex vivo stimulation of Mycobacterium tuberculosis-specific T cells by genetically detoxified Bordetella pertussis adenylate cyclase antigen toxoids. Infect Immun (2005) 0.95

Recognition of mycobacterial antigens delivered by genetically detoxified Bordetella pertussis adenylate cyclase by T cells from cattle with bovine tuberculosis. Infect Immun (2004) 0.93

Delivery of a MalE CD4(+)-T-cell epitope into the major histocompatibility complex class II antigen presentation pathway by Bordetella pertussis adenylate cyclase. Infect Immun (2002) 0.92

Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis. J Virol (2005) 0.90

MGL signaling augments TLR2-mediated responses for enhanced IL-10 and TNF-α secretion. J Leukoc Biol (2013) 0.90

The adenylate cyclase toxin from Bordetella pertussis--a novel promising vehicle for antigen delivery to dendritic cells. Int J Med Microbiol (2004) 0.90

Carbohydrate antigens: synthesis aspects and immunological applications in cancer. Mini Rev Med Chem (2006) 0.89

The B subunit of Shiga toxin coupled to full-size antigenic protein elicits humoral and cell-mediated immune responses associated with a Th1-dominant polarization. Int Immunol (2003) 0.89

Adenylate cyclase toxin translocates across target cell membrane without forming a pore. Mol Microbiol (2010) 0.88

CD4-independent protective cytotoxic T cells induced in early life by a non-replicative delivery system based on virus-like particles. Virology (2003) 0.88

In vivo receptor-mediated delivery of a recombinant invasive bacterial toxoid to CD11c + CD8 alpha -CD11bhigh dendritic cells. Eur J Immunol (2002) 0.88

Purification of splenic dendritic cells induces maturation and capacity to stimulate Th1 response in vivo. Int Immunol (2006) 0.87

Induction of protective antiviral cytotoxic T cells by a tubular structure capable of carrying large foreign sequences. Vaccine (2002) 0.87

Partial activation of neonatal CD11c+ dendritic cells and induction of adult-like CD8+ cytotoxic T cell responses by synthetic microspheres. J Immunol (2004) 0.86

Tn glycosylation of the MUC6 protein modulates its immunogenicity and promotes the induction of Th17-biased T cell responses. J Biol Chem (2010) 0.86

The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells. Cancer Res (2009) 0.86

Induction of HLA-A2-restricted CTL responses by a tubular structure carrying human melanoma epitopes. Vaccine (2002) 0.85

The shift of Th1 to Th2 immunodominance associated with the chronicity of Mycobacterium bovis bacille Calmette-Guérin infection does not affect the memory response. J Immunol (2003) 0.85

Fetal spleen stroma drives macrophage commitment. Development (2006) 0.85

Cross-priming of T cell responses by synthetic microspheres carrying a CD8+ T cell epitope requires an adjuvant signal. J Immunol (2005) 0.85

Calcium influx rescues adenylate cyclase-hemolysin from rapid cell membrane removal and enables phagocyte permeabilization by toxin pores. PLoS Pathog (2012) 0.85

Personality characteristics and attachment in first episode psychosis: impact on social functioning. J Nerv Ment Dis (2007) 0.85

Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes. Int Immunol (2003) 0.85

Inhibition of phagosome maturation by mycobacteria does not interfere with presentation of mycobacterial antigens by MHC molecules. J Immunol (2007) 0.85

Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin. Int J Cancer (2011) 0.85

Neonatal plasmacytoid dendritic cells (pDCs) display subset variation but can elicit potent anti-viral innate responses. PLoS One (2013) 0.85

Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer. Cancer Immunol Immunother (2013) 0.85

Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination. Glycobiology (2006) 0.84

Pivotal role of plasmacytoid dendritic cells in inflammation and NK-cell responses after TLR9 triggering in mice. Blood (2012) 0.84

Processing of the bovine spongiform encephalopathy-specific prion protein by dendritic cells. J Virol (2006) 0.84

Induction of anti-Tat neutralizing antibodies by the CyaA vector targeting dendritic cells: influence of the insertion site and of the delivery of multicopies of the dominant Tat B-cell epitope. Vaccine (2010) 0.82

Poly(I:C)-induced protection of neonatal mice against intestinal Cryptosporidium parvum infection requires an additional TLR5 signal provided by the gut flora. J Infect Dis (2013) 0.82

Group CBT for early psychosis--are there still benefits one year later? Int J Group Psychother (2012) 0.82

Immobilized cytokines as biomaterials for manufacturing immune cell based vaccines. J Biomed Mater Res A (2008) 0.81

Do people with a first episode of psychosis differ in personality profiles? Schizophr Res (2006) 0.81

Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant. Blood (2010) 0.81

Change in jumping to conclusions linked to change in delusions in early psychosis. Schizophr Res (2013) 0.81

Spirituality and religion in outpatients with schizophrenia: a multi-site comparative study of Switzerland, Canada, and the United States. Int J Psychiatry Med (2012) 0.81